Yahoo Finance

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Seeking Alpha

Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone

PONTE VEDRA, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...
Nasdaq

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
Business Insider

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...

Treace Medical Concepts Q4 Earnings Call Highlights

Treace Medical Concepts (NASDAQ:TMCI) management told investors it is entering what it called a “transformational phase,” expanding beyond its historical Lapiplasty focus to become a broader ...
Mena FN

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightningtm Technology

(MENAFN- GlobeNewsWire - Nasdaq) PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the“Company”) (NasdaqGS: TMCI), a medical technology company driving a ...